Cti Biopharma Corp buy Needham & Company LLC
Start price
20.04.23
/
50%
€4.61
Target price
20.04.24
€8.20
Performance (%)
81.37%
End price
21.04.24
-
Summary
This prediction is currently being closed. With a performance of 81.37% the BUY prediction by Needham___Company_LL is a big success. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cti Biopharma Corp | - | - | - |
iShares Core DAX® | -0.922% | -1.993% | 13.399% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% |
Comments by Needham___Company_LL for this prediction
In the thread Cti Biopharma Corp diskutieren
CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $9.00 price target on the stock.
Ratings data for CTIC provided by MarketBeat
In the thread Trading Cti Biopharma Corp
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten